Carea, a pregnancy and postnatal wellbeing app that prioritises women’s health, has launched the Postpartum Mum Tracker to support the 1 in 5 new mothers who face post-birth mental health struggles.
A research team led by two University of Maine Ph.D. students developed an artificial intelligence (AI) system that could make it easier and faster for doctors to identify signs of breast cancer in tissue samples, possibly preventing delays and saving lives.
FRANKLIN LAKES, N.J., Nov. 17, 2025 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the Conformité Européenne (CE) Marked BD Onclarity™ HPV Assay for the BD COR™ System and the BD Viper™ LT System have been accepted for the World Health Organization (WHO) list of prequalified in vitro diagnostic products, further expanding access to high-quality cervical cancer screening tools in low- and middle-income countries.
Researchers at the University of California San Diego School of Medicine have identified a promising new therapy for triple-negative breast cancer (TNBC), which is among the most aggressive and difficult-to-treat forms of the disease.
In a move for women’s health, menstrual health startup Joii is launching the world’s first AI-powered app that accurately measures period blood volume in the UK, transforming a guessing game into hard data that benefits patients and clinicians alike.
New research reveals a drug developed by scientists at Oregon Health & Science University may develop into a new treatment for an especially aggressive form of breast cancer.
A rigorous systematic review of the present state of knowledge on the use of acetaminophen during pregnancy and the risk of specific neurodevelopmental disorders (NDDs), such as autism and ADHD, offers reassurance that acetaminophen does not increase the risk of NDDs.
The human genome is riddled with relics of viral infections—bits of DNA from viruses that have been inserted in human DNA over millions of years and never left. Most are silent but some have taken on functional roles, particularly in organs that evolve relatively rapidly, including the placenta.
Designed as a safe, accessible, and office-based alternative to surgical sterilization, FemBloc represents a paradigm shift in permanent contraception
Pulsenmore announced today that it received FDA de novo clearance for its home-use prenatal ultrasound platform.